GSK Latest Headlines

GSK’s RTS,S Malaria Vaccine Study Nears the Finish Line With Fresh 2026 Update

at www.tipranks.com (Mon, 2-Mar 11:30 AM)

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

at www.tipranks.com (Mon, 2-Mar 7:17 AM)

Deal Dispatch: Funko For Sale? Caesars Casino Weighs Offers, iPic Bankrupt

at www.benzinga.com (Fri, 27-Feb 4:05 PM)

GSK Discloses Dividend-Funded ADS Acquisition by U.S. President Martinez-Davis

at www.tipranks.com (Fri, 27-Feb 12:58 PM)

GSK’s Greener Inhaler Trial Reaches Completion: What Investors Should Watch

at www.tipranks.com (Fri, 27-Feb 11:30 AM)

GSK Buys Back 545,000 Shares as Treasury Stock in February Programme

at www.tipranks.com (Fri, 27-Feb 8:40 AM)

FDA reportedly eyeing staff bonuses to accelerate drug reviews

at seekingalpha.com (Thu, 26-Feb 1:35 PM)

Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

at www.tipranks.com (Thu, 26-Feb 10:35 AM)

GSK’s Bepirovirsen Wins First Global Regulatory Review in Japan for Chronic Hepatitis B

at www.tipranks.com (Thu, 26-Feb 7:29 AM)

GSK’s Linerixibat Wins Priority Review in China for PBC-Related Itch

at www.tipranks.com (Thu, 26-Feb 7:27 AM)

GSK Expands February Buyback, Lifts Treasury Stake to 5.97%

at www.tipranks.com (Thu, 26-Feb 7:08 AM)

GlaxoSmithKline (GSK) Receives a Hold from UBS

at www.tipranks.com (Thu, 26-Feb 4:48 AM)

GSK’s AREXVY Shows 75.6% Effectiveness in Reducing RSV Hospitalizations and Related Health Risks in Real-World Study

Market Chameleon (Wed, 18-Feb 8:31 AM)

GSK Teams Up With Summit to Advance Novel Antibody Drug Combination in Solid Tumor Cancers

Market Chameleon (Mon, 12-Jan 7:11 AM)

FDA Greenlights GSK’s Exdensur, Offering Twice-Yearly Asthma Protection and 58% Reduction in Exacerbations

Market Chameleon (Wed, 17-Dec 7:56 AM)